BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25355974)

  • 1. Changes in immunization program managers' perceptions of programs' functional capabilities during and after vaccine shortages and pH1N1.
    Moriarty LF; Omer SB; Seib K; Chamberlain A; Wells K; Whitney E; Berkelman R; Bednarczyk RA
    Public Health Rep; 2014; 129 Suppl 4(Suppl 4):42-8. PubMed ID: 25355974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.
    Chamberlain AT; Wells K; Seib K; Kudis A; Hannan C; Orenstein WA; Whitney EA; Hinman AR; Buehler JW; Omer SB; Berkelman RL
    J Public Health Manag Pract; 2012; 18(3):E9-E16. PubMed ID: 22473128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
    Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
    Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of immunization program managers on 2009-10 H1N1 vaccination in the United States: a national survey.
    Chamberlain AT; Seib K; Wells K; Hannan C; Orenstein WA; Whitney EA; Hinman AR; Berkelman RL; Omer SB
    Biosecur Bioterror; 2012 Mar; 10(1):142-50. PubMed ID: 22360580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the most effective distribution strategies to assure administration of pandemic H1N1 influenza vaccine to New York State children and adolescents: evaluation using the New York State Immunization Information System.
    Bednarczyk RA; DuVall S; Meldrum MD; Flynn MK; Santilli LA; Easton DE; Sharma P; Blog DS; Zansky SM; McNutt LA; Birkhead GS
    J Public Health Manag Pract; 2013; 19(6):589-97. PubMed ID: 23299656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(33):1069-72. PubMed ID: 20798669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.
    Charania NA; Moghadas SM
    BMC Public Health; 2017 Sep; 17(1):705. PubMed ID: 28903749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hib vaccine: should it be introduced in the national immunization program?
    Taneja DK
    Indian J Public Health; 2012; 56(3):177-9. PubMed ID: 23229207
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease.
    Fry AM; Lurie P; Gidley M; Schmink S; Lingappa J; Fischer M; Rosenstein NE
    Pediatrics; 2001 Oct; 108(4):E60. PubMed ID: 11581468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(3):58-60. PubMed ID: 19177041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):673-4. PubMed ID: 19553904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The introduction of Haemophilus influenzae type b immunization into the United Kingdom: practical steps to assure success.
    Salisbury DM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S136-9. PubMed ID: 9781747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaching children never previously vaccinated for influenza through a school-located vaccination program.
    Kansagra SM; Papadouka V; Geevarughese A; Hansen MA; Konty KJ; Zucker JR
    Am J Public Health; 2014 Jan; 104(1):e45-9. PubMed ID: 24228652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.